NIM
VYGR icon

Needham Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Needham Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-141,924
Closed -$1.01M – 121
2020
Q4 		$1.01M Sell
141,924
-23,076
-14% -$222K 0.17% 84
2020
Q3 		$1.76M Buy
165,000
+75,000
+83% +$880K 0.35% 64
2020
Q2 		$1.14M Hold
90,000
– – 0.24% 70
2020
Q1 		$824K Buy
90,000
+70,000
+350% +$803K 0.23% 76
2019
Q4 		$279K Buy
+20,000
New +$291K 0.08% 92

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Needham Investment Management's VYGR Position: Q1 2021 in Review

Needham Investment Management sold out of Voyager Therapeutics (VYGR) in Q1 2021, closing a stake of 141,924 shares — an estimated $1.01M sold.

Needham Investment Management first reported a position in VYGR in Q4 2019 and held it in 5 quarters. The position peaked at $1.76M in Q3 2020. 101 funds tracked by Wall St. Rank hold VYGR as of Q1 2021.

  • Needham Investment Management reported no remaining Voyager Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Needham Investment Management sold 141,924 Voyager Therapeutics shares in Q1 2021, an estimated $1.01M.
  • Needham Investment Management first reported a position in Voyager Therapeutics in Q4 2019 and held it in 5 quarters.
  • Needham Investment Management's Voyager Therapeutics position peaked at $1.76M in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2021.

Based on Needham Investment Management's 13F filing for Q1 2021, filed 17 May 2021.